Three subtypes of distinct pathological proteins accumulate throughout multiple brain regions and shape the heterogeneous clinical presentation of frontotemporal lobar degeneration (FTLD). Beside the main pathological subtypes, co-occurring pathologies are common in FTLD brain donors. The objective of this study is to investigate how the location and burden of (co-)pathology correlate to early psychiatric and behavioural symptoms of FTLD. Eighty-seven brain donors from the Netherlands Brain Bank cohort (2008-2017) diagnosed with FTLD were included: 46 FTLD-TAR DNA-binding protein 43 (FTLD-TDP), 34 FTLD-tau, and seven FTLD-fused-in-sarcoma (FTLD-FUS). Post-mortem brain tissue was dissected into 20 standard regions and stained for phosphoryla...
Through an international consortium, we have collected 37 tau- and TAR DNA-binding protein 43 (TDP-4...
Frontotemporal dementia (FTD) is a spectrum of clinically and pathologically heterogenous neurodegen...
Through an international consortium, we have collected 37 tau- and TAR DNA-binding protein 43 (TDP-4...
Three subtypes of distinct pathological proteins accumulate throughout multiple brain regions and sh...
BACKGROUND: Distinct pathologies accumulate in multiple brain regions (BR) and shape the heterogeneo...
Objective: The pathology of frontotemporal dementia, termed frontotemporal lobar degeneration (FTLD)...
Objective: The pathology of frontotemporal dementia, termed frontotemporal lobar degeneration (FTLD)...
Frontotemporal dementia (FTD) is the clinical term for a heterogeneous group of dementia disorders w...
The primary goal of this article is to critically discuss the syndromic overlap that exists between ...
To further characterize the neuropathology of the heterogeneous molecular disorder frontotemporal lo...
ABSTRACT Frontotemporal lobar degeneration (FTLD) is the second most common cause of presenile demen...
Frontotemporal dementia (FTD) is a spectrum of clinically and pathologically heterogenous neurodegen...
Abstract Background We aimed to systematically descri...
Frontotemporal dementia (FTD) is a clinical syndrome with a heterogeneous molecular basis. The neuro...
Accurately predicting the underlying neuropathological diagnosis in patients with behavioural varian...
Through an international consortium, we have collected 37 tau- and TAR DNA-binding protein 43 (TDP-4...
Frontotemporal dementia (FTD) is a spectrum of clinically and pathologically heterogenous neurodegen...
Through an international consortium, we have collected 37 tau- and TAR DNA-binding protein 43 (TDP-4...
Three subtypes of distinct pathological proteins accumulate throughout multiple brain regions and sh...
BACKGROUND: Distinct pathologies accumulate in multiple brain regions (BR) and shape the heterogeneo...
Objective: The pathology of frontotemporal dementia, termed frontotemporal lobar degeneration (FTLD)...
Objective: The pathology of frontotemporal dementia, termed frontotemporal lobar degeneration (FTLD)...
Frontotemporal dementia (FTD) is the clinical term for a heterogeneous group of dementia disorders w...
The primary goal of this article is to critically discuss the syndromic overlap that exists between ...
To further characterize the neuropathology of the heterogeneous molecular disorder frontotemporal lo...
ABSTRACT Frontotemporal lobar degeneration (FTLD) is the second most common cause of presenile demen...
Frontotemporal dementia (FTD) is a spectrum of clinically and pathologically heterogenous neurodegen...
Abstract Background We aimed to systematically descri...
Frontotemporal dementia (FTD) is a clinical syndrome with a heterogeneous molecular basis. The neuro...
Accurately predicting the underlying neuropathological diagnosis in patients with behavioural varian...
Through an international consortium, we have collected 37 tau- and TAR DNA-binding protein 43 (TDP-4...
Frontotemporal dementia (FTD) is a spectrum of clinically and pathologically heterogenous neurodegen...
Through an international consortium, we have collected 37 tau- and TAR DNA-binding protein 43 (TDP-4...